Wolf Group Capital Advisors Has $400,000 Position in UnitedHealth Group Incorporated (NYSE:UNH)

Wolf Group Capital Advisors lowered its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 73.1% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 763 shares of the healthcare conglomerate's stock after selling 2,071 shares during the quarter. Wolf Group Capital Advisors' holdings in UnitedHealth Group were worth $400,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the stock. Fort Washington Investment Advisors Inc. OH raised its position in UnitedHealth Group by 0.3% during the first quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate's stock worth $277,641,000 after acquiring an additional 1,465 shares in the last quarter. Waycross Partners LLC raised its holdings in shares of UnitedHealth Group by 2.4% in the 4th quarter. Waycross Partners LLC now owns 27,794 shares of the healthcare conglomerate's stock valued at $14,060,000 after purchasing an additional 658 shares during the period. Sherbrooke Park Advisers LLC bought a new position in UnitedHealth Group during the fourth quarter worth about $515,000. Full Sail Capital LLC raised its stake in UnitedHealth Group by 2.1% in the fourth quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate's stock valued at $815,000 after buying an additional 33 shares during the period. Finally, Soros Fund Management LLC acquired a new position in shares of UnitedHealth Group during the 4th quarter worth approximately $39,413,000. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Trading Up 0.5%

NYSE UNH opened at $309.14 on Wednesday. UnitedHealth Group Incorporated has a 12 month low of $248.88 and a 12 month high of $630.73. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. The firm has a market capitalization of $280.43 billion, a PE ratio of 12.95, a price-to-earnings-growth ratio of 1.44 and a beta of 0.44. The business's 50-day moving average price is $376.32 and its two-hundred day moving average price is $469.08.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. The firm had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same quarter in the previous year, the business posted $6.91 EPS. On average, analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 24th. Investors of record on Monday, June 16th will be paid a dividend of $2.21 per share. The ex-dividend date is Monday, June 16th. This represents a $8.84 annualized dividend and a yield of 2.86%. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's dividend payout ratio (DPR) is currently 37.02%.

Analyst Ratings Changes

Several research firms have commented on UNH. KeyCorp decreased their price objective on shares of UnitedHealth Group from $450.00 to $400.00 and set an "overweight" rating on the stock in a report on Monday, June 2nd. Argus cut shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Monday, April 21st. Wolfe Research decreased their target price on UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating on the stock in a research report on Tuesday, May 20th. Raymond James Financial cut UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a report on Wednesday, May 14th. Finally, Erste Group Bank cut UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, April 30th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have issued a buy rating to the company. Based on data from MarketBeat.com, UnitedHealth Group has a consensus rating of "Moderate Buy" and a consensus price target of $426.52.

Insider Buying and Selling at UnitedHealth Group

In other news, Director Timothy Patrick Flynn purchased 1,533 shares of the business's stock in a transaction on Wednesday, May 14th. The shares were acquired at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the acquisition, the director now owns 6,033 shares in the company, valued at approximately $1,935,386.40. The trade was a 34.07% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director John H. Noseworthy bought 300 shares of the stock in a transaction that occurred on Wednesday, May 14th. The stock was acquired at an average price of $312.16 per share, for a total transaction of $93,648.00. Following the acquisition, the director now directly owns 6,063 shares in the company, valued at $1,892,626.08. The trade was a 5.21% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last three months, insiders have acquired 109,408 shares of company stock valued at $31,607,768. 0.28% of the stock is currently owned by company insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.